Skip to Main content Skip to Navigation
Journal articles

Type 1 interferons as a potential treatment against COVID-19

Abstract : Type 1 interferons have a broad antiviral activity in vitro and are currently evaluated in a clinical trial to treat MERS-CoV. In this review, we discuss preliminary data concerning the potential activity of type 1 interferons on SARS-CoV-2, and the relevance of evaluating these molecules in clinical trials for the treatment of COVID-19.
Complete list of metadata
Contributor : Myriam Bodescot Connect in order to contact the contributor
Submitted on : Friday, April 17, 2020 - 5:05:14 PM
Last modification on : Thursday, April 7, 2022 - 1:58:23 PM

Links full text



Erwan Sallard, François-Xavier Lescure, yazdan yazdanpanah, France Mentré, Nathan Peiffer-Smadja. Type 1 interferons as a potential treatment against COVID-19. Antiviral Research, Elsevier Masson, 2020, 178, pp.104791. ⟨10.1016/j.antiviral.2020.104791⟩. ⟨inserm-02546137⟩



Record views